The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, M.
Right arrow Articles by McGhee, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, M.
Right arrow Articles by McGhee, J. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 161: 4115-4121.
Copyright © 1998 by The American Association of Immunologists

A Nontoxic Adjuvant for Mucosal Immunity to Pneumococcal Surface Protein A1

Masafumi Yamamoto*,{dagger}, David E. Briles*, Shingo Yamamoto*, Mari Ohmura*, Hiroshi Kiyono*,{dagger} and Jerry R. McGhee2,*

* Immunobiology Vaccine Center, Departments of Oral Biology and Microbiology, University of Alabama Medical Center, Birmingham, AL 35294; and {dagger} Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

In this study, we demonstrated that pneumococcal surface protein A (PspA) nasally administered with a nontoxic A subunit mutant of cholera toxin (mCT) S61F elicited a protective immune response. Immunization with PspA and mCT elicited higher levels of PspA-specific IgG and IgA Abs in serum and of IgG and IgA anti-PspA Ab-forming cells in spleens, cervical lymph nodes (CLN), and lung tissue when compared to nonimmunized mice. Furthermore, significant PspA-specific IgA Abs were induced in saliva and nasal secretions. These responses were dependent on the use of mCT as a mucosal adjuvant. The PspA-specific Ab responses induced by mCT S61F were comparable with those induced by native CT (nCT). Analysis of cytokine responses showed that nasal PspA plus mCT S61F enhanced the induction of PspA-specific CD4+ T cells producing IL-4 but not IFN-{gamma} in CLN at both the protein and mRNA levels. Importantly, significant numbers of mice intranasally immunized with PspA plus mCT S61F were protected from lethal challenge with capsular serotype 3 Streptococcus pneumoniae A66. These results show that intranasal administration of PspA together with mCT S61F is an effective mucosal vaccine against pneumococcal infection and induces CD4+ Th2-type cells, which provide help for both mucosal and systemic Ab responses.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
F. Momoi, T. Hashizume, T. Kurita-Ochiai, Y. Yuki, H. Kiyono, and M. Yamamoto
Nasal Vaccination with the 40-Kilodalton Outer Membrane Protein of Porphyromonas gingivalis and a Nontoxic Chimeric Enterotoxin Adjuvant Induces Long-Term Protective Immunity with Reduced Levels of Immunoglobulin E Antibodies
Infect. Immun., June 1, 2008; 76(6): 2777 - 2784.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Hagiwara, Y. I. Kawamura, K. Kataoka, B. Rahima, R. J. Jackson, K. Komase, T. Dohi, P. N. Boyaka, Y. Takeda, H. Kiyono, et al.
A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking.
J. Immunol., September 1, 2006; 177(5): 3045 - 3054.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. W. van Ginkel, R. J. Jackson, N. Yoshino, Y. Hagiwara, D. J. Metzger, T. D. Connell, H. L. Vu, M. Martin, K. Fujihashi, and J. R. McGhee
Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract
Infect. Immun., October 1, 2005; 73(10): 6892 - 6902.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-Y. Ko, H.-J. Ko, W.-S. Chang, S.-H. Park, M.-N. Kweon, and C.-Y. Kang
{alpha}-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor
J. Immunol., September 1, 2005; 175(5): 3309 - 3317.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Kobayashi, T. Kohda, K. Kataoka, H. Ihara, S. Kozaki, D. W. Pascual, H. F. Staats, H. Kiyono, J. R. McGhee, and K. Fujihashi
A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism
J. Immunol., February 15, 2005; 174(4): 2190 - 2195.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. A. Green, Y. Zhang, A. W. Masi, V. Barniak, M. Wetherell, R. P. Smith, M. S. Reddy, and D. Zhu
PppA, a Surface-Exposed Protein of Streptococcus pneumoniae, Elicits Cross-Reactive Antibodies That Reduce Colonization in a Murine Intranasal Immunization and Challenge Model
Infect. Immun., February 1, 2005; 73(2): 981 - 989.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Yoshino, F. X.-S. Lu, K. Fujihashi, Y. Hagiwara, K. Kataoka, D. Lu, L. Hirst, M. Honda, F. W. van Ginkel, Y. Takeda, et al.
A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates
J. Immunol., December 1, 2004; 173(11): 6850 - 6857.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Kataoka, J. R. McGhee, R. Kobayashi, K. Fujihashi, S. Shizukuishi, and K. Fujihashi
Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity
J. Immunol., March 15, 2004; 172(6): 3612 - 3619.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. J. Berry, D. K. Hickey, K. A. Skelding, S. Bao, A. M. Rendina, P. M. Hansbro, C. M. Gockel, and K. W. Beagley
Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection
Infect. Immun., February 1, 2004; 72(2): 1019 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. N. Boyaka, A. Tafaro, R. Fischer, S. H. Leppla, K. Fujihashi, and J. R. McGhee
Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen
J. Immunol., June 1, 2003; 170(11): 5636 - 5643.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. N. Boyaka, M. Ohmura, K. Fujihashi, T. Koga, M. Yamamoto, M.-N. Kweon, Y. Takeda, R. J. Jackson, H. Kiyono, Y. Yuki, et al.
Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit
J. Immunol., January 1, 2003; 170(1): 454 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. P. Arulanandam, J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger
Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity against Streptococcus pneumoniae Infection
Infect. Immun., November 1, 2001; 69(11): 6718 - 6724.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kunisawa, T. Nakanishi, I. Takahashi, A. Okudaira, Y. Tsutsumi, K. Katayama, S. Nakagawa, H. Kiyono, and T. Mayumi
Sendai Virus Fusion Protein-Mediates Simultaneous Induction of MHC Class I/II-Dependent Mucosal and Systemic Immune Responses Via the Nasopharyngeal-Associated Lymphoreticular Tissue Immune System
J. Immunol., August 1, 2001; 167(3): 1406 - 1412.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Y. Zhang, A. W. Masi, V. Barniak, K. Mountzouros, M. K. Hostetter, and B. A. Green
Recombinant PhpA Protein, a Unique Histidine Motif-Containing Protein from Streptococcus pneumoniae, Protects Mice against Intranasal Pneumococcal Challenge
Infect. Immun., June 1, 2001; 69(6): 3827 - 3836.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. W. van Ginkel, R. J. Jackson, Y. Yuki, and J. R. McGhee
Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues
J. Immunol., November 1, 2000; 165(9): 4778 - 4782.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Koga, J. R. McGhee, H. Kato, R. Kato, H. Kiyono, and K. Fujihashi
Evidence For Early Aging in the Mucosal Immune System
J. Immunol., November 1, 2000; 165(9): 5352 - 5359.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Agren, E. Sverremark, L. Ekman, K. Schon, B. Lowenadler, C. Fernandez, and N. Lycke
The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects
J. Immunol., June 15, 2000; 164(12): 6276 - 6286.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Kodama, S. Suenaga, T. Hirano, M. Suzuki, and G. Mogi
Induction of Specific Immunoglobulin A and Th2 Immune Responses to P6 Outer Membrane Protein of Nontypeable Haemophilus influenzae in Middle Ear Mucosa by Intranasal Immunization
Infect. Immun., April 1, 2000; 68(4): 2294 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. E. Briles, E. Ades, J. C. Paton, J. S. Sampson, G. M. Carlone, R. C. Huebner, A. Virolainen, E. Swiatlo, and S. K. Hollingshead
Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage of Streptococcus pneumoniae
Infect. Immun., February 1, 2000; 68(2): 796 - 800.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. P. Simmons, P. Mastroeni, R. Fowler, M. Ghaem-maghami, N. Lycke, M. Pizza, R. Rappuoli, and G. Dougan
MHC Class I-Restricted Cytotoxic Lymphocyte Responses Induced by Enterotoxin-Based Mucosal Adjuvants
J. Immunol., December 15, 1999; 163(12): 6502 - 6510.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. W. Pascual, D. M. Hone, S. Hall, F. W. van Ginkel, M. Yamamoto, N. Walters, K. Fujihashi, R. J. Powell, S. Wu, J. L. Vancott, et al.
Expression of Recombinant Enterotoxigenic Escherichia coli Colonization Factor Antigen I by Salmonella typhimurium Elicits a Biphasic T Helper Cell Response
Infect. Immun., December 1, 1999; 67(12): 6249 - 6256.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Yamamoto, H. Kiyono, S. Yamamoto, E. Batanero, M.-N. Kweon, S. Otake, M. Azuma, Y. Takeda, and J. R. McGhee
Direct Effects on Antigen-Presenting Cells and T Lymphocytes Explain the Adjuvanticity of a Nontoxic Cholera Toxin Mutant
J. Immunol., June 15, 1999; 162(12): 7015 - 7021.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Yanagita, T. Hiroi, N. Kitagaki, S. Hamada, H.-o Ito, H. Shimauchi, S. Murakami, H. Okada, and H. Kiyono
Nasopharyngeal-Associated Lymphoreticular Tissue (NALT) Immunity: Fimbriae-Specific Th1 and Th2 Cell-Regulated IgA Responses for the Inhibition of Bacterial Attachment to Epithelial Cells and Subsequent Inflammatory Cytokine Production
J. Immunol., March 15, 1999; 162(6): 3559 - 3565.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.